-+ 0.00%
-+ 0.00%
-+ 0.00%

Recursion Pharmaceuticals director Christopher Gibson disposes of 40,000 common shares for $ 123,200

PUBT·05/27/2026 20:16:23
Listen to the news
Recursion Pharmaceuticals director Christopher Gibson disposes of 40,000 common shares for $ 123,200
  • Recursion Pharmaceuticals director Christopher Gibson sold 40,000 Class A common shares on May 22 at USD 3.08.
  • He ended the day with 883,735 Class A shares, following a same-day 40,000-share Class B-to-Class A conversion at USD 0.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recursion Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001856369-26-000019), on May 27, 2026, and is solely responsible for the information contained therein.